Copy
June 2016

iMTA NEWSLETTER 

The summer has arrived, the UK voted 'out', and The Netherlands is not in UEFA EURO 2016. In the meantime, we simply continue doing health economic stuff. Wishing you all a great summer.

 

In this issue

13 language translations for iMTA Productivity Cost Questionnaire

The iMTA Productivity Cost Questionnaire (iPCQ) standardizes the measurement of productivity losses for economic evaluations and has been published by Bouwman et al in Value in Health in 2016. The iPCQ includes three modules measuring productivity losses of paid work due to 1) absenteeism and 2) presenteeism and productivity losses related to 3) unpaid work. The questionnaire is now available in: Czech, Danish, German, English, Spanish, French, Hungarian, Italian, Dutch, Norwegian, Polish, Portuguese and Romanian. Questionnaires available at imta.nl/questionnaires.

A simple tool to calculate severity of disease (Beta)

The iMTA Disease Burden Calculator uses life tables and quality of life adjustments to calculate the severity of a disease in terms of 'proportional shortfall' and 'fair innings'.

In The Netherlands, the cost-effectiveness threshold depends on the severity ('ziektelast') of the condition it treats: when the severity is higher, a higher cost-effectiveness threshold applies. iMTA made a simple tool, the iMTA Disease Burden Calculator (iDBC) to standardize the assessment of severity.  Due to high demand, the current version 1.3 beta of the tool has been posted online, which only calculates values for The Netherlands.


Download the tool here: https://www.imta.nl/idbc/

COPD burden of disease 

COPD is a pulmonary disease with an impact on quality of life that goes beyond airway limitation. iMTA’s Lucas Goossens and Maureen Rutten used the Assessment of Burden of Disease (ABC) tool In a discrete choice experiment to quantify what consequences of the disease result in the most severe burden of disease and develop a score to express the overall burden.

They found that patients regard fatigue and being severely limited in their activities as burdensome as the occurrence of exacerbations. The ABC index is predictive of healthcare consumption in the period after measurement. The results of the study will be published and presented widely.

Updated version PAID

The Practical Application to Include Disease costs (PAID) has been updated to version 1.1. This is a major update as it is built on the most recent (2013) cost of illness data available. Please find the most recent version here: imta.nl/paid

Vacancy

iMTA is hiring! We are looking for a health economic modeller. Interested? Visit www.imta.nl/vacancy 


PhD Theses completed in Q1 - 2016


Leander Buisman. Early cost-effectiveness of medical tests in rheumatoid arthritis and ischemic stroke. [Completed, awaiting online publication]

Hedwig Blommestein. The added value of real-world evidence. [Completed, awaiting online publication]

Liesbeth Lawerman-van de Wetering. Valuing and refining outcome measures for economic evaluations in health care. [Completed, awaiting online publication]

 

PhD theses completed in 2015


Melinde Boland. Cost-effectiveness of disease management programs in COPD. Find full thesis here: http://repub.eur.nl/pub/79692

Laura Burgers. Challenges in assessing the cost-effectiveness of cardiovascular technologiesFind full thesis here: http://repub.eur.nl/pub/79724

Naomi van der Linden. The use of real-world data in lung and head and neck oncology. Find full thesis here: http://repub.eur.nl/pub/78915

Renske Hoefman. The impact of caregiving. Find full thesis here: http://repub.eur.nl/pub/78028

Annemieke Leunis. The cost-effectiveness of personalized medicine strategies in acute myeloid leukemia.  Find full thesis here: http://repub.eur.nl/pub/78280

Apostolos Tsiachristas. Payment and Economic Evaluation of Integrated Care. Find full thesis here: http://repub.eur.nl/pub/77857

Visit imta.nl

 

iMTA

Copyright © 2016 Institute for Medical Technology Assessment, All rights reserved.
Email Marketing Powered by MailChimp